524 related articles for article (PubMed ID: 16248551)
1. Soy processing affects metabolism and disposition of dietary isoflavones in ovariectomized BALB/c mice.
Allred CD; Twaddle NC; Allred KF; Goeppinger TS; Churchwell MI; Ju YH; Helferich WG; Doerge DR
J Agric Food Chem; 2005 Nov; 53(22):8542-50. PubMed ID: 16248551
[TBL] [Abstract][Full Text] [Related]
2. Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits.
McCarty MF
Med Hypotheses; 2006; 66(6):1093-114. PubMed ID: 16513288
[TBL] [Abstract][Full Text] [Related]
3. Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice.
Ju YH; Fultz J; Allred KF; Doerge DR; Helferich WG
Carcinogenesis; 2006 Apr; 27(4):856-63. PubMed ID: 16399773
[TBL] [Abstract][Full Text] [Related]
4. Increased probiotic yogurt or resistant starch intake does not affect isoflavone bioavailability in subjects consuming a high soy diet.
Larkin TA; Price WE; Astheimer LB
Nutrition; 2007 Oct; 23(10):709-18. PubMed ID: 17656069
[TBL] [Abstract][Full Text] [Related]
5. Concentrations of isoflavones in macaques consuming standard laboratory monkey diet.
Stroud FC; Appt SE; Wilson ME; Franke AA; Adams MR; Kaplan JR
J Am Assoc Lab Anim Sci; 2006 Jul; 45(4):20-3. PubMed ID: 16884174
[TBL] [Abstract][Full Text] [Related]
6. Distribution of isoflavones in samples of serum, liver and mammary glands of rats or pigs fed dietary isoflavones.
Gilani GS; Farmer C; Dyck M; Robertson P; Dahiya J; Sepehr E; Fan L; Nicolidakis H; Curran I; Cooke GM
Ann Nutr Metab; 2011; 58(3):171-80. PubMed ID: 21654164
[TBL] [Abstract][Full Text] [Related]
7. Soy processing influences growth of estrogen-dependent breast cancer tumors.
Allred CD; Allred KF; Ju YH; Goeppinger TS; Doerge DR; Helferich WG
Carcinogenesis; 2004 Sep; 25(9):1649-57. PubMed ID: 15131010
[TBL] [Abstract][Full Text] [Related]
8. One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women.
Védrine N; Mathey J; Morand C; Brandolini M; Davicco MJ; Guy L; Rémésy C; Coxam V; Manach C
Eur J Clin Nutr; 2006 Sep; 60(9):1039-45. PubMed ID: 16482068
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability and urinary excretion of isoflavones in humans: effects of soy-based supplements formulation and equol production.
Vergne S; Titier K; Bernard V; Asselineau J; Durand M; Lamothe V; Potier M; Perez P; Demotes-Mainard J; Chantre P; Moore N; Bennetau-Pelissero C; Sauvant P
J Pharm Biomed Anal; 2007 Mar; 43(4):1488-94. PubMed ID: 17110073
[TBL] [Abstract][Full Text] [Related]
10. Growth performance, carcass characteristics and bioavailability of isoflavones in pigs fed soy bean based diets.
Kuhn G; Hennig U; Kalbe C; Rehfeldt C; Ren MQ; Moors S; Degen GH
Arch Anim Nutr; 2004 Aug; 58(4):265-76. PubMed ID: 15570741
[TBL] [Abstract][Full Text] [Related]
11. Effect of glycosidation of isoflavones on their bioavailability and pharmacokinetics in aged male rats.
Sepehr E; Cooke GM; Robertson P; Gilani GS
Mol Nutr Food Res; 2009 May; 53 Suppl 1():S16-26. PubMed ID: 19437481
[TBL] [Abstract][Full Text] [Related]
12. Enhanced estrogenic responses and sensitivity to azoxymethane following dietary soy isoflavone supplementation in older female rats.
Daly KT; Tracy AC; Malik M; Wang T; Francke-Carroll S; Magnuson BA
Food Chem Toxicol; 2007 Apr; 45(4):628-37. PubMed ID: 17157426
[TBL] [Abstract][Full Text] [Related]
13. Absorption of isoflavones in humans: effects of food matrix and processing.
de Pascual-Teresa S; Hallund J; Talbot D; Schroot J; Williams CM; Bugel S; Cassidy A
J Nutr Biochem; 2006 Apr; 17(4):257-64. PubMed ID: 16109484
[TBL] [Abstract][Full Text] [Related]
14. The effect of the phytoestrogens genistein, daidzein, and equol on the growth of tamoxifen-resistant T47D/PKC alpha.
Tonetti DA; Zhang Y; Zhao H; Lim SB; Constantinou AI
Nutr Cancer; 2007; 58(2):222-9. PubMed ID: 17640169
[TBL] [Abstract][Full Text] [Related]
15. Estrogenicity of the isoflavone metabolite equol on reproductive and non-reproductive organs in mice.
Selvaraj V; Zakroczymski MA; Naaz A; Mukai M; Ju YH; Doerge DR; Katzenellenbogen JA; Helferich WG; Cooke PS
Biol Reprod; 2004 Sep; 71(3):966-72. PubMed ID: 15151933
[TBL] [Abstract][Full Text] [Related]
16. Review of the factors affecting bioavailability of soy isoflavones in humans.
Nielsen IL; Williamson G
Nutr Cancer; 2007; 57(1):1-10. PubMed ID: 17516857
[TBL] [Abstract][Full Text] [Related]
17. Phytoestrogens and breast cancer: a complex story.
Helferich WG; Andrade JE; Hoagland MS
Inflammopharmacology; 2008 Oct; 16(5):219-26. PubMed ID: 18815740
[TBL] [Abstract][Full Text] [Related]
18. Higher bioavailability of isoflavones after a single ingestion of a soya-based supplement than a soya-based food in young healthy males.
Vergne S; Bennetau-Pelissero C; Lamothe V; Chantre P; Potier M; Asselineau J; Perez P; Durand M; Moore N; Sauvant P
Br J Nutr; 2008 Feb; 99(2):333-44. PubMed ID: 17678570
[TBL] [Abstract][Full Text] [Related]
19. Soy extract is more potent than genistein on tumor growth inhibition.
Kim HA; Jeong KS; Kim YK
Anticancer Res; 2008; 28(5A):2837-41. PubMed ID: 19035319
[TBL] [Abstract][Full Text] [Related]
20. On-line sample preparation using restricted-access media in the analysis of the soy isoflavones, genistein and daidzein, in rat serum using liquid chromatography electrospray mass spectrometry.
Doerge DR; Churchwell MI; Delclos KB
Rapid Commun Mass Spectrom; 2000; 14(8):673-8. PubMed ID: 10786906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
